Skip to main content
Log in

Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group

  • Original Contribution
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract

Tic disorders have a strong male predominance, with a male-to-female ratio of 4:1 in Tourette syndrome (TS) and 2:1 in persistent tic disorders. In other neurodevelopmental conditions, such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), the disparity in sex distribution has been partially related to differences in symptom presentation between males and females. In tic disorders, however, little research has been conducted on this topic, probably due to the limited access to large samples with a significant proportion of females. The aim of this study was to describe sex differences in the clinical presentation of tic disorders in children and adolescents in one of the largest pediatric samples with TS/persistent tic disorders (n = 709, 23.3% females) recruited as part of the European Multicenter Tics in Children Study (EMTICS). Validated measures assessed the severity of tics and comorbid psychiatric symptoms. Using mixed-effect models, we found that sex had a significant influence on the severity of tics, ADHD symptoms, ASD symptoms, and emotional problems. Males had more severe symptoms than females, except for emotional problems. We also observed a statistically significant interaction between sex and age on the severity of tics and compulsions, with females showing higher symptom severity with increasing age than males. These findings indicate that the clinical presentation of TS/persistent tic disorders varies with sex. Males seem to exhibit a more noticeable pattern of clinical symptoms at a younger age that may contribute to their earlier detection in comparison to females.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

* statistical significant at 0.05 level. YGTSS Yale Global Tics Severity Scale, CY-BOCS Children’s Yale-Brown Obsessive Compulsive Scale, ADHD Attention/Deficit and Hyperactivity Disorder, SNAP-IV Swanson Nolan and Pelham-IV rating scale, ASD Autism Spectrum Disorder, ASSQ Autism Spectrum Screening Questionnaire, SDQ Strengths and Difficulties Questionnaire

Similar content being viewed by others

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. American Psychiatry Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatry Press, Washington

    Book  Google Scholar 

  2. Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS, Peterson BS (1998) Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102(1 Pt 1):14–19. https://doi.org/10.1542/peds.102.1.14

    Article  CAS  PubMed  Google Scholar 

  3. Bloch MH, Leckman JF (2009) Clinical course of Tourette syndrome. J Psychosom Res 67(6):497–501. https://doi.org/10.1016/j.jpsychores.2009.09.002

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gorman DA, Thompson N, Plessen KJ, Robertson MM, Leckman JF, Peterson BS (2010) Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study. Br J Psychiatry 197(1):36–44. https://doi.org/10.1192/bjp.bp.109.071050

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H, Lin H, Bentley MJ, Gilbert DL, Singer HS, Coffey BJ, Kurlan RM, Leckman JF, Tourette Syndrome Study G (2012) Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 21(8):451–457. https://doi.org/10.1007/s00787-012-0278-5

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C, King RA, Sandor P, McMahon WM, Lyon GJ, Cath DC, Kurlan R, Robertson MM, Osiecki L, Scharf JM, Mathews CA, Tourette Syndrome Association International Consortium for G (2015) Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry 72(4):325–333. https://doi.org/10.1001/jamapsychiatry.2014.2650

    Article  PubMed  PubMed Central  Google Scholar 

  7. Martino D, Ganos C, Pringsheim TM (2017) Tourette syndrome and chronic tic disorders: the clinical spectrum beyond tics. Int Rev Neurobiol 134:1461–1490. https://doi.org/10.1016/bs.irn.2017.05.006

    Article  PubMed  Google Scholar 

  8. Khalifa N, von Knorring AL (2005) Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background. Acta Paediatr 94(11):1608–1614. https://doi.org/10.1111/j.1651-2227.2005.tb01837.x

    Article  PubMed  Google Scholar 

  9. Santangelo SL, Pauls DL, Goldstein JM, Faraone SV, Tsuang MT, Leckman JF (1994) Tourette’s syndrome: What are the influences of gender and comorbid obsessive-compulsive disorder? J Am Acad Child Adolesc Psychiatry 33(6):795–804. https://doi.org/10.1097/00004583-199407000-00004

    Article  CAS  PubMed  Google Scholar 

  10. Rynkiewicz A, Schuller B, Marchi E, Piana S, Camurri A, Lassalle A, Baron-Cohen S (2016) An investigation of the “female camouflage effect” in autism using a computerized ADOS-2 and a test of sex/gender differences. Mol Autism 7:10. https://doi.org/10.1186/s13229-016-0073-0

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mowlem FD, Rosenqvist MA, Martin J, Lichtenstein P, Asherson P, Larsson H (2019) Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur Child Adolesc Psychiatry 28(4):481–489. https://doi.org/10.1007/s00787-018-1211-3

    Article  PubMed  Google Scholar 

  12. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P (2000) An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries. Dev Med Child Neurol 42(7):436–447. https://doi.org/10.1017/s0012162200000839

    Article  CAS  PubMed  Google Scholar 

  13. Viana MC, Andrade LH (2012) Lifetime Prevalence, age and gender distribution and age-of-onset of psychiatric disorders in the Sao Paulo Metropolitan Area, Brazil: results from the Sao Paulo Megacity Mental Health Survey. Braz J Psychiatry 34(3):249–260. https://doi.org/10.1016/j.rbp.2012.03.001

    Article  PubMed  Google Scholar 

  14. Mandy W, Chilvers R, Chowdhury U, Salter G, Seigal A, Skuse D (2012) Sex differences in autism spectrum disorder: evidence from a large sample of children and adolescents. J Autism Dev Disord 42(7):1304–1313. https://doi.org/10.1007/s10803-011-1356-0

    Article  PubMed  Google Scholar 

  15. Lewin AB, Murphy TK, Storch EA, Conelea CA, Woods DW, Scahill LD, Compton SN, Zinner SH, Budman CL, Walkup JT (2012) A phenomenological investigation of women with Tourette or other chronic tic disorders. Compr Psychiatry 53(5):525–534. https://doi.org/10.1016/j.comppsych.2011.07.004

    Article  PubMed  Google Scholar 

  16. Edwards KR, Raines JM, Winnick JB, Sherman MF, Higginson CI, Navin K, Conteh F, Ricketts EJ, Specht MW (2020) Sex and psychiatric comorbidity correlates of the premonitory urge for tic scale in youth with persistent tic disorders. J Neural Transm (Vienna) 127(6):977–985. https://doi.org/10.1007/s00702-020-02151-9

    Article  CAS  Google Scholar 

  17. Lichter DG, Finnegan SG (2015) Influence of gender on Tourette syndrome beyond adolescence. Eur Psychiatry 30(2):334–340. https://doi.org/10.1016/j.eurpsy.2014.07.003

    Article  CAS  PubMed  Google Scholar 

  18. Groth C, Mol Debes N, Rask CU, Lange T, Skov L (2017) Course of tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry 56(4):304–312. https://doi.org/10.1016/j.jaac.2017.01.010

    Article  PubMed  Google Scholar 

  19. Schrag A, Martino D, Apter A, Ball J, Bartolini E, Benaroya-Milshtein N, Buttiglione M, Cardona F, Creti R, Efstratiou A, Gariup M, Georgitsi M, Hedderly T, Heyman I, Margarit I, Mir P, Moll N, Morer A, Muller N, Muller-Vahl K, Munchau A, Orefici G, Plessen KJ, Porcelli C, Paschou P, Rizzo R, Roessner V, Schwarz MJ, Steinberg T, Tagwerker Gloor F, Tarnok Z, Walitza S, Dietrich A, Hoekstra PJ, Group EC (2019) European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents. Eur Child Adolesc Psychiatry 28(1):91–109. https://doi.org/10.1007/s00787-018-1190-4

    Article  PubMed  Google Scholar 

  20. American Psychiatry Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatry Press, Washington

    Google Scholar 

  21. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989) The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28(4):566–573. https://doi.org/10.1097/00004583-198907000-00015

    Article  CAS  PubMed  Google Scholar 

  22. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF (1997) Children’s Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36(6):844–852. https://doi.org/10.1097/00004583-199706000-00023

    Article  CAS  PubMed  Google Scholar 

  23. Lewin AB, Piacentini J, De Nadai AS, Jones AM, Peris TS, Geffken GR, Geller DA, Nadeau JM, Murphy TK, Storch EA (2014) Defining clinical severity in pediatric obsessive-compulsive disorder. Psychol Assess 26(2):679–684. https://doi.org/10.1037/a0035174

    Article  PubMed  Google Scholar 

  24. Swanson JM, Schuck S, Porter MM, Carlson C, Hartman CA, Sergeant JA, Clevenger W, Wasdell M, McCleary R, Lakes K, Wigal T (2012) Categorical and dimensional definitions and evaluations of symptoms of ADHD: history of the SNAP and the SWAN rating scales. Int J Educ Psychol Assess 10(1):51–70

    PubMed  PubMed Central  Google Scholar 

  25. Ehlers S, Gillberg C, Wing L (1999) A screening questionnaire for Asperger syndrome and other high-functioning autism spectrum disorders in school age children. J Autism Dev Disord 29(2):129–141. https://doi.org/10.1023/a:1023040610384

    Article  CAS  PubMed  Google Scholar 

  26. Goodman R (1997) The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 38(5):581–586. https://doi.org/10.1111/j.1469-7610.1997.tb01545.x

    Article  CAS  PubMed  Google Scholar 

  27. Bloch MH, Craiglow BG, Landeros-Weisenberger A, Dombrowski PA, Panza KE, Peterson BS, Leckman JF (2009) Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics 124(4):1085–1093. https://doi.org/10.1542/peds.2009-0015

    Article  PubMed  Google Scholar 

  28. de Mathis MA, Diniz JB, Shavitt RG, Torres AR, Ferrao YA, Fossaluza V, Pereira C, Miguel E, do Rosario MC (2009) Early onset obsessive-compulsive disorder with and without tics. CNS Spectr 14 (7):362-370. doi:https://doi.org/10.1017/s1092852900023014

  29. Mathes BM, Morabito DM, Schmidt NB (2019) Epidemiological and clinical gender differences in OCD. Curr Psychiatry Rep 21(5):36. https://doi.org/10.1007/s11920-019-1015-2

    Article  PubMed  Google Scholar 

  30. Geller DA (2006) Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 29(2):353–370. https://doi.org/10.1016/j.psc.2006.02.012

    Article  PubMed  Google Scholar 

  31. Loomes R, Hull L, Mandy WPL (2017) What Is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 56(6):466–474. https://doi.org/10.1016/j.jaac.2017.03.013

    Article  PubMed  Google Scholar 

  32. Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD (2010) Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry 49 (3):217–228 e211–213

  33. Gaub M, Carlson CL (1997) Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 36(8):1036–1045. https://doi.org/10.1097/00004583-199708000-00011

    Article  CAS  PubMed  Google Scholar 

  34. Graetz BW, Sawyer MG, Baghurst P (2005) Gender differences among children with DSM-IV ADHD in Australia. J Am Acad Child Adolesc Psychiatry 44(2):159–168. https://doi.org/10.1097/00004583-200502000-00008

    Article  PubMed  Google Scholar 

  35. Halladay AK, Bishop S, Constantino JN, Daniels AM, Koenig K, Palmer K, Messinger D, Pelphrey K, Sanders SJ, Singer AT, Taylor JL, Szatmari P (2015) Sex and gender differences in autism spectrum disorder: summarizing evidence gaps and identifying emerging areas of priority. Mol Autism 6:36. https://doi.org/10.1186/s13229-015-0019-y

    Article  PubMed  PubMed Central  Google Scholar 

  36. Tillmann J, Ashwood K, Absoud M, Bolte S, Bonnet-Brilhault F, Buitelaar JK, Calderoni S, Calvo R, Canal-Bedia R, Canitano R, De Bildt A, Gomot M, Hoekstra PJ, Kaale A, McConachie H, Murphy DG, Narzisi A, Oosterling I, Pejovic-Milovancevic M, Persico AM, Puig O, Roeyers H, Rommelse N, Sacco R, Scandurra V, Stanfield AC, Zander E, Charman T (2018) Evaluating sex and age differences in ADI-R and ADOS scores in a large European multi-site sample of individuals with autism spectrum disorder. J Autism Dev Disord 48(7):2490–2505. https://doi.org/10.1007/s10803-018-3510-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 (1):8–19. doi:https://doi.org/10.1001/archpsyc.1994.03950010008002

  38. Dwyer SB, Nicholson JM, Battistutta D (2006) Parent and teacher identification of children at risk of developing internalizing or externalizing mental health problems: a comparison of screening methods. Prev Sci 7(4):343–357. https://doi.org/10.1007/s11121-006-0026-5

    Article  PubMed  Google Scholar 

  39. Huisman-van Dijk HM, Matthijssen S, Stockmann RTS, Fritz AV, Cath DC (2019) Effects of comorbidity on Tourette’s tic severity and quality of life. Acta Neurol Scand 140(6):390–398. https://doi.org/10.1111/ane.13155

    Article  PubMed  PubMed Central  Google Scholar 

  40. Benaroya-Milshtein N, Shmuel-Baruch S, Apter A, Valevski A, Fenig S, Steinberg T (2020) Aggressive symptoms in children with tic disorders. Eur Child Adolesc Psychiatry 29(5):617–624. https://doi.org/10.1007/s00787-019-01386-6

    Article  PubMed  Google Scholar 

  41. Lavigne JV, Bryant FB, Hopkins J, Gouze KR (2015) Dimensions of oppositional defiant disorder in young children: model comparisons, gender and longitudinal invariance. J Abnorm Child Psychol 43(3):423–439. https://doi.org/10.1007/s10802-014-9919-0

    Article  PubMed  Google Scholar 

  42. Tackett JL, Krueger RF, Iacono WG, McGue M (2005) Symptom-based subfactors of DSM-defined conduct disorder: evidence for etiologic distinctions. J Abnorm Psychol 114(3):483–487. https://doi.org/10.1037/0021-843X.114.3.483

    Article  PubMed  PubMed Central  Google Scholar 

  43. INSERM Collective Expertise Centre. INSERM Collective Expert Reports [Internet]. Paris: Institut national de la santé et de la recherche médicale; 2000-. Conduct: Disorder in children and adolescents. 2005. https://www-ncbi-nlm-nih-gov.proxy-ub.rug.nl/books/NBK7133/

Download references

Acknowledgements

The authors are deeply grateful to all children and their parents who willingly participated to make this research possible. This research was supported by the Deutsche Forschungsgemeinschaft (DFG): projects 1692/3-1, 4-1, SFB 936, and FOR 2698 (project numbers 396914663, 396577296, 396474989) (Münchau). We thank all colleagues at the various study centers who contributed to data collection: Julie E. Bruun, Judy Grejsen, Christine L. Ommundsen, Mette Rubæk (Capital Region Psychiatry, Copenhagen, Denmark); Benjamin Bodmer, Stephanie Enghardt (TUD Dresden, Germany); Stefanie Bokemeyer, Christiane Driedger-Garbe, Cornelia Reichert (MHH Hannover, Germany); Jenny Schmalfeld (Lübeck University, Germany); Victoria L. Turner, Martin L. Woods (Evelina London Children’s Hospital, United Kingdom); Franciska Gergye, Margit Kovacs, Reka Vidomusz (Vadaskert Budapest, Hungary); Silvana Fennig, Ella Gev, Matan Nahon, Danny Horesh, Chen Regev, Tomer Simcha, (Tel Aviv, Petah-Tikva, Israel); Els van den Ban, Sebastian F.T.M. de Bruijn, Nicole Driessen, Andreas Lamerz, Marieke Messchendorp, Judith J.G. Rath, Nadine Schalk, Deborah Sival, Noor Tromp, Frank Visscher and the Stichting Gilles de la Tourettes (UMCG Groningen, Netherlands); Maria Teresa Cáceres, Fátima Carrillo, Pilar Gómez-Garre, Laura Vargas, Ángela Periañez Vasco (Hospital Virgen del Rocío, Seville, Spain); Giuseppe Gagliardi (ASL Bari, Italy); Paolo Roazzi, Marco Tallon (ISS Rome, Italy); Maria Gariup, Marina Redondo (Hospital Clinic Barcelona, Spain); and all who may not have been mentioned. EMTICS group authorship/appendix: EMTICS group members are Alan Apter1, Valentina Baglioni2, Juliane Ball3, Noa Benaroya-Milshtein1, Emese Bognar4,5, Bianka Burger6,7, Judith Buse8, Francesco Cardona2, Marta Correa Vela9, Nanette M. Debes10, Andrea Dietrich11, Maria Cristina Ferro12, Carolin Fremer13, Blanca Garcia-Delgar14, Mariangela Gulisano12, Annelieke Hagen15,16, Julie Hagstrøm17, Tammy J. Hedderly18, Isobel Heyman19, Pieter J. Hoekstra11, Chaim Huyser15,16, Marcos Madruga-Garrido20, Anna Marotta21, Davide Martino22, Pablo Mir9, Astrid Morer14,23,24, Norbert Müller6,7, Kirsten Müller-Vahl13, Alexander Münchau25, Peter Nagy4,26, Valeria Neri2, Thaïra J.C. Openneer11, Alessandra Pellico12, Kerstin J. Plessen17,27, Cesare Porcelli21, Renata Rizzo12, Veit Roessner8, Daphna Ruhrman1, Jaana M.L. Schnell6, Paola Rosaria Silvestri2, Liselotte Skov10, Tamar Steinberg1, Friederike Tagwerker Gloor3, Zsanett Tarnok4, Susanne Walitza3, Elif Weidinger 6. 1Child and Adolescent Psychiatry Department, Schneider Children's Medical Center of Israel, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Petah-Tikva, Israel. 2University La Sapienza of Rome, Department of Human Neurosciences, Rome, Italy. 3Clinic of Child and Adolescent Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland. 4Vadaskert Child and Adolescent Psychiatric Hospital, Budapest, Hungary. 5Semmelweis University, Bókay Children's Clinic, Budapest, Hungary. 6Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany. 7Marion von Tessin Memory-Zentrum gGmbH, Munich, Germany. 8Department of Child and Adolescent Psychiatry, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany. 9Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clinica. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain. 10Paediatric Department, Herlev University Hospital, Herlev, Denmark. 11University of Groningen, University Medical Center Groningen, Department of Child and Adolescent Psychiatry, Groningen, The Netherlands. 12Child Neuropsychiatry Section, Department of Clinical and Experimental Medicine, School of Medicine, Catania University, Catania, Italy. 13Clinic of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany. 14Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clinic Universitari, Barcelona, Spain. 15De Bascule, Academic Center for Child and Adolescent Psychiatry, Amsterdam, The Netherlands. 16Academic Medical Center, Department of Child and Adolescent Psychiatry, Amsterdam, The Netherlands. 17Child and Adolescent Mental Health Center, Mental Health Services, Capital Region of Denmark and University of Copenhagen, Copenhagen, Denmark. 18Evelina London Children’s Hospital GSTT, Kings Health Partners AHSC, London, UK. 19 Great Ormond Street Hospital for Children, and UCL Institute of Child Health, London, UK. 20Sección de Neuropediatría, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain. 21Azienda Sanitaria Locale di Bari, Mental Health Department, Child and Adolescent Service of Bari Metropolitan Area, Bari, Italy. 22Department of Clinical Neurosciences, University of Calgary, Calgary, Canada. 23Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. 24Centro de Investigacion en Red de Salud Mental (CIBERSAM), Instituto Carlos III, Spain. 25Institute of Systems Motor Science, University of Lübeck, Lübeck, Germany. 26Bethesda Children's Hospital, Budapest, Hungary. 27Division of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland

Funding

This project has received funding from the European Union's Seventh Framework Program for Research, technological development and demonstration under grant agreement no 278367.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Blanca Garcia-Delgar.

Ethics declarations

Conflict of interest

Coffey is on the Scientific Advisory Board of Abide Therapeutics and Teva/ Nuvelution, has received honoraria from the American Academy of Child and Adolescent Psychiatry, Partners Healthcare, Harvard Medical School, Teva, CME Outfitters, University of Cincinnati, University of Texas Medical Branch, and University of Florida, and has received research support from Teva/ Nuvelution, Inc., Neurocrine Biosciences, Emalex, the National Institute of Mental Health (Grant No. 5R01MH115959-02), and University of California San Francisco. Müller-Vahl received funding for research from the EU (FP7-PEOPLE-2012-ITN No. 316978), the German Research Society (DFG: GZ MU 1527/3–1), the German Ministry of Education and Research (BMBF: 01KG1421), the National Institute of Mental Health (NIMH), GW, Almirall, Abide Therapeutics, and Therapix Biosiences, and consultant’s honoraria from Abide Therapeutics, Fundacion Canna, and Therapix Biosiences. On behalf of all other authors, the corresponding author declares that the other authors have no conflict of interest.

Ethics approval and consent to participate

The EMTICS study was approved by the local research ethics committees of each participating center and in accordance with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all parents or legal guardians, and children and adolescents were asked to sign informed assent forms when appropriate.

Additional information

List of authors present in the EMTICS collaborative group is in acknowledgment.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garcia-Delgar, B., Servera, M., Coffey, B.J. et al. Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group. Eur Child Adolesc Psychiatry 31, 1539–1548 (2022). https://doi.org/10.1007/s00787-021-01751-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-021-01751-4

Keywords

Navigation